tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT
US Market

Immunovant (IMVT) Ownership - Who Owns Immunovant?

Compare
819 Followers

Immunovant (IMVT) Ownership Overview

2.73%15.46%24.73%7.86%49.22%
24.73% Other Institutional Investors
7.86% ETFs
49.22% Public Companies and
Individual Investors
The ownership structure of Immunovant (IMVT) stock is a mix of institutional, retail, and individual investors. Approximately 48.05% of the company’s stock is owned by Institutional Investors, 2.73% is owned by Insiders, and 49.22% is owned by Public Companies and Individual Investors.
The ownership structure of Immunovant (IMVT) stock is a mix of institutional, retail, and individual investors. Approximately 40.19% of the company’s stock is owned by Institutional Investors, 2.73% is owned by Insiders, and 7.86% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 17, 2025
xxxxxxxxxxxxx
$44566
Apr 17, 2025
xxxxxxxxxxxxx
$123900
Apr 11, 2025
xxxxxxxxxxxxx
$143708
Apr 11, 2025
xxxxxxxxxxxxx
$364941

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$5011540
Dec 31, 2024
xxxxxxxxxxxxx
$15920323
Dec 31, 2024
xxxxxxxxxxxxx
$34858573
Dec 31, 2024
xxxxxxxxxxxxx
$42304212

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
96,650,341Insider56.90%1,494,697,524
6,473,786Institution3.81%100,117,100
5,879,977Institution3.46%90,933,844
5,539,942Institution3.26%85,675,203
2,941,018Institution1.73%45,482,843
2,139,199Institution1.26%33,082,713
2,052,193Institution1.21%31,737,165
1,882,886Institution1.11%29,118,832
1,707,881Institution1.01%26,412,380
1,407,290Institution0.83%21,763,740

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
5,879,977Institution3.46%90,933,844
5,539,942Institution3.26%85,675,203
2,052,193Institution1.21%31,737,165
1,089,037Institution0.64%16,841,957
964,372Institution0.57%14,914,013
665,621Institution0.39%10,293,829
642,615Institution0.38%9,938,041
616,891Institution0.36%9,540,219
510,490Institution0.30%7,894,728
425,290Institution0.25%6,577,110

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,088,072Institution1.23%43,014,283
1,734,649Institution1.02%26,765,634
1,682,053Institution0.99%41,664,453
1,482,126Institution0.87%22,921,079
1,108,724Institution0.65%22,839,714
1,006,461Institution0.59%20,733,097
520,203Institution0.31%8,044,939
446,793Institution0.26%6,909,654
360,298Institution0.21%5,559,398
265,956Institution0.16%5,478,694

FAQ

Who Owns Immunovant (IMVT)?
According to the latest TipRanks data, approximately 24.73% of the company's stock is held by institutional investors, 2.73% is held by insiders, and 49.22% is held by retail investors.
    What percentage of Immunovant (IMVT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 24.73% of Immunovant (IMVT) stock is held by institutional investors.
      What percentage of Immunovant (IMVT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 49.22% of Immunovant (IMVT) stock is held by retail investors.
        Who owns the most shares of Immunovant (IMVT)?
        Roivant Sciences Ltd. owns the most shares of Immunovant (IMVT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis